Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message|
( followers)  

The following is a Q/Q comparison of Icahn Capital's holdings, as reported in yesterday's SEC filing. For this article, we only focus on common shares.

New Positions

  • Anadarko Petroleum Corporation (NYSE:APC): New position valued at $72,180,000
  • The Hain Celestial Group, Inc. (NASDAQ:HAIN): New position valued at $58,503,000
  • Lawson Software, Inc. (NASDAQ:LWSN): New position valued at $55,541,000
  • Mentor Graphics Corp. (NASDAQ:MENT): New position valued at $55,003,000
  • NRG Energy, Inc. (NYSE:NRG): New position valued at $50,414,000
  • MICROS Systems, Inc. (NASDAQ:MCRS): New position valued at $20,874,000
  • Smith & Wesson Holding Corporation (NASDAQ:SWHC): New position valued at $9,722,000

click for expanded images

Increased Positions

  • Chesapeake Energy Corporation (NYSE:CHK): Boosted holdings by $216,705,000 ($50,187,000 reported on May 17, vs. $266,892,000 reported on Aug. 16)
  • Lions Gate Entertainment Corp. (NYSE:LGF): Boosted holdings by $113,669,000 ($109,710,000 reported on May 17, vs. $223,379,000 reported on Aug. 16)
  • Motorola Inc. (MOT): Boosted holdings by $61,716,000 ($1,096,664,000 reported on May 17, vs. $1,158,380,000 reported on Aug. 16)
  • Cyberonics Inc. (NASDAQ:CYBX): Boosted holdings by $9,528,000 ($40,389,000 reported on May 17, vs. $49,917,000 reported on Aug. 16)
  • Enzon Pharmaceuticals Inc. (NASDAQ:ENZN): Boosted holdings by $1,324,000 ($28,676,000 reported on May 17, vs. $30,000,000 reported on Aug. 16)

Reduced Positions

  • Biogen Idec Inc. (NASDAQ:BIIB): Reduced position by $127,444,000 ($737,661,000 reported on May 17, vs. $610,217,000 reported on Aug. 16)
  • Amylin Pharmaceuticals, Inc. (AMLN): Reduced position by $47,864,000 ($291,725,000 reported on May 17, vs. $243,861,000 reported on Aug. 16)
  • Genzyme Corp. (GENZ): Reduced position by $11,108,000 ($543,178,000 reported on May 17, vs. $532,070,000 reported on Aug. 16)
  • Yahoo! Inc. (NASDAQ:YHOO): Reduced position by $10,912,000 ($66,804,000 reported on May 17, vs. $55,892,000 reported on Aug. 16)
  • Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Reduced position by $10,192,000 ($64,744,000 reported on May 17, vs. $54,552,000 reported on Aug. 16)
  • Take-Two Interactive Software Inc. (NASDAQ:TTWO): Reduced position by $6,688,000 ($91,570,000 reported on May 17, vs. $84,882,000 reported on Aug. 16)
  • Exelixis, Inc. (NASDAQ:EXEL): Reduced position by $6,129,000 ($14,308,000 reported on May 17, vs. $8,179,000 reported on Aug. 16)
  • Forest Laboratories Inc. (NYSE:FRX): Reduced position by $4,767,000 ($38,043,000 reported on May 17, vs. $33,276,000 reported on Aug. 16)
  • Wendy's/Arby's Group, Inc. (NASDAQ:WEN): Reduced position by $644,000 ($3,218,000 reported on May 17, vs. $2,574,000 reported on Aug. 16)

Disclosure: No positions

Source: 13-F Filing: Q/Q Comparison of Carl Icahn's Portfolio Holdings